Inventor · disambiguated record
David T. Dudley
Also filed as: DUDLEY DAVID T · DUDLEY DAVID THOMAS
10 granted patents·6 pending applications·370 citations·filing 1992–2020
92Inventor score
Top patents by PatentIndex Score
16 records- 0198US6310060B12-(4-bromo or 4-iodo phenylamino) benzoic acid derivatives and their use as MEK inhibitorsWARNER LAMBERT CO·Filed 1998·Granted Oct 30, 2001·146 cites·37 claims
- 0297US7169816B24-bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitorsWARNER LAMBERT CO·Filed 2005·Granted Jan 30, 2007·30 cites·16 claims
- 0397US6821963B24-Bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitorsWARNER LAMBERT CO·Filed 2002·Granted Nov 23, 2004·52 cites·21 claims
- 0493US7019033B22-(4-bromo or 4-iodo phenylamino) benzoic acid derivativesWARNER LAMBERT CO·Filed 2002·Granted Mar 28, 2006·26 cites·11 claims
- 0587US6492363B22-(4-bromo or 4-iodo phenylamino) benzoic acid derivativesWARNER LAMBERT CO·Filed 2001·Granted Dec 10, 2002·14 cites·35 claims
- 0680US5338744AAngiotensin II antagonists used to treat reproductive functions associated with AT2 receptorsWARNER LAMBERT CO·Filed 1992·Granted Aug 16, 1994·40 cites·3 claims
- 0772US6696440B1Treatment of asthma with MEK inhibitorsWARNER LAMBERT CO·Filed 1999·Granted Feb 24, 2004·34 cites·13 claims
- 0862US8975029B2Integrin alpha-2 binding agents and use thereof to inhibit cancer cell proliferationWEISS STEPHEN J·Filed 2012·Granted Mar 10, 2015·1 cites·10 claims
- 0961US2020254077A1Materials and Methods for Eliciting Targeted Antibody Responses In VivoUNIV MICHIGAN REGENTS·Filed 2020·Application pending·0 cites
- 1058US6251943B1Method of treating or preventing septic shock by administering a MEK inhibitorWARNER LAMBERT CO·Filed 1997·Granted Jun 26, 2001·18 cites·9 claims
- 1156US2018228880A1Materials and Methods for Eliciting Targeted Antibody Responses In VivoUNIV MICHIGAN REGENTS·Filed 2017·Application pending·0 cites
- 1254US2005049429A14-Bromo or 4-iodo phenylamino benzhydroxamic acid derivatives and their use as MEK inhibitorsFiled 2004·Application pending·0 cites
- 1353US5444069AImidazo-pyridine angiotensin II antagonists used to treat memory lossWARNER LAMBERT CO·Filed 1994·Granted Aug 22, 1995·9 cites·3 claims
- 1451US2015174224A1Materials and Methods for Eliciting Targeted Antibody Responses In VivoUNIV MICHIGAN·Filed 2015·Application pending·0 cites
- 1551US2004141924A1Treatment of asthma with MEK inhibitorsFiled 2004·Application pending·0 cites
- 1642US2003224500A1Modified MEK1 and MEK2, crystal of a peptide: ligand: cofactor complex containing such modified MEK1 or MEK2, and methods of use thereofFiled 2002·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when David T. Dudley files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →